article thumbnail

Understanding the role of recombinant insulin in cell culture systems: What the studies say 

Pharmaceutical Technology

Among several growth-promoting supplements added to the cell culture media formulations, insulin is one of the most common. Recombinant insulin is used as a supplement in the upstream manufacturing of a range of biologic drugs, including recombinant proteins, such as monoclonal antibodies, viral vectors, and viruses.

Insulin 130
article thumbnail

Cell culture Q&A: Solving biomanufacturing challenges with Recombinant Insulin supplementation

Pharmaceutical Technology

It is no exaggeration to say that the world changed in the early 80s when insulin was expressed synthetically in microorganisms for the first time. This breakthrough led to a recombinant (biosynthetic) and thereby safer therapy for diabetes than the animal-sourced insulin which had been used since 1922.

Insulin 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

XTalks

A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals.

article thumbnail

“Patients are only numbers on an Excel spreadsheet”

World of DTC Marketing

” According to data from the People’s Vaccine Alliance, Pfizer, BioNTech, and Moderna make $65k a minute in combined profits from their vaccines, based on profits reported in the three companies’ latest reports. Today pharma is about “business.”

Insulin 259
article thumbnail

Looking back at 2022: The top healthcare stories

Pharmaceutical Technology

Reynald Castaneda wrote about the affected clinical trial ecosystems in both countries , while Fiona Barry and Manasi analysed the impact of the war on the supply of the Russian Covid-19 vaccine Sputnik V to the rest of the world.

article thumbnail

Phase 3 trial dashes Oramed’s oral insulin hopes

pharmaphorum

Oramed Pharma has conceded defeat in its attempt to bring an oral formulation of insulin to market for people with type 2 diabetes, after its ORMD-0801 candidate missed the mark in a phase 3 trial. The post Phase 3 trial dashes Oramed’s oral insulin hopes appeared first on.

Insulin 59
article thumbnail

Researchers Develop Arthritis Vaccine + Medtronic Expands Recall on Insulin Pumps – Xtalks Life Science Podcast Ep. 32

XTalks

In addition to timely diagnosis, there may soon be a preventative vaccine for inflammatory arthritic conditions such as rheumatoid arthritis. Researchers at the University of Toledo have developed a vaccine against inflammatory arthritis that has shown promise in animal models. The recalls affect almost half a million devices combined.

Insulin 45